LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Photo from wikipedia

Steffen Boettcher (University of Zurich and University Hospital Zurich, Switzerland) Roman Schimmer (University of Zurich and University Hospital Zurich, Switzerland) Larisa Kovtonyuk (University of Hospital Zurich and University of Zurich,… Click to show full abstract

Steffen Boettcher (University of Zurich and University Hospital Zurich, Switzerland) Roman Schimmer (University of Zurich and University Hospital Zurich, Switzerland) Larisa Kovtonyuk (University of Hospital Zurich and University of Zurich, Switzerland) Nancy Klemm (University of Zurich and University Hospital Zurich, Switzerland) Jonas Fullin (University of Zurich and University Hospital Zurich, Switzerland) Sebastian Stolz (University Hospital Zurich, Switzerland) Jan Mueller (University of Zurich and University Hospital Zurich, Switzerland) Kari Kurppa (Institute of Biomedicine and MediCity Research Laboratories, Finland) Benjamin Ebert (Dana-Farber Cancer Institute, United States) Markus Manz (University Hospital Zurich and University of Zurich, Switzerland) Caiado Francisco (University of Zurich and University Hospital Zurich, Switzerland)

Keywords: university hospital; university; zurich; zurich switzerland; hospital zurich

Journal Title: Blood Advances
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.